Demo Data from SIGIR 2026 / reviewers in the wild / expert
Daria A. Gaykalova
dblp:209/7602
· DBLP profile ↗
3ranked-venue papers
0as first author
0since 2021 · last 2019
0000-0001-5037-0147ORCID · corroborated
Domains — the database's venue-derived domains; a paper can count in several
Applied, interdisciplinary, general and emerging computing · 3
Expertise — from the expertise taxonomy: the topics of the expert's papers under the CCF categories. A weight counts papers with recency: 1 for a paper about the topic, 0.3 when the topic is its context, halved every five years.
| Interdisciplinary, comprehensive, and emerging computing
2 papers |
Bioinformatics and computational biology · 80% Medical and health informatics · 20% |
Topics — the 6 heaviest of 7, each with the papers that count most for it
| Topic | Weight | Papers | Last | Evidence papers |
|---|---|---|---|---|
Medical and health informatics › biomedical data science › cancer informatics
cancer data analysis |
0.3 | 1 | 2018 | Splice Expression Variation Analysis (SEVA) for inter-tumor heterogeneity of gene isoform usage in cancer · Bioinform. 2018 |
Bioinformatics and computational biology
genomics |
0.3 | 1 | 2018 | Splice Expression Variation Analysis (SEVA) for inter-tumor heterogeneity of gene isoform usage in cancer · Bioinform. 2018 |
Bioinformatics and computational biology › transcriptomics
RNA-seq analysis |
0.3 | 1 | 2018 | Splice Expression Variation Analysis (SEVA) for inter-tumor heterogeneity of gene isoform usage in cancer · Bioinform. 2018 |
Bioinformatics and computational biology › cancer genomics
tumor heterogeneity |
0.3 | 1 | 2018 | Splice Expression Variation Analysis (SEVA) for inter-tumor heterogeneity of gene isoform usage in cancer · Bioinform. 2018 |
Bioinformatics and computational biology
gene expression analysis |
0.3 | 1 | 2017 | PatternMarkers & GWCoGAPS for novel data-driven biomarkers via whole transcriptome NMF · Bioinform. 2017 |
Bioinformatics and computational biology
biomarker discovery |
0.1 | 1 | 2017 | PatternMarkers & GWCoGAPS for novel data-driven biomarkers via whole transcriptome NMF · Bioinform. 2017 |
Methods — techniques the papers use, named apart from their topics
rank-based multivariate statistic · 0.3MCMC · 0.3CoGAPS · 0.3Bayesian NMF · 0.3
| Year | Publication | Venue | Position |
|---|---|---|---|
| 2019 | CancerInSilico: An R/Bioconductor package for combining mathematical and statistical modeling to simulate time course bulk and single cell gene expression data in cancerabstractBioinformatics techniques to analyze time course bulk and single cell omics data are advancing. The absence of a known ground truth of the dynamics of molecular changes challenges benchmarking their performance on real data. Realistic simulated time-course datasets are essential to assess the performance of time course bioinformatics algorithms. We develop an R/Bioconductor package, CancerInSilico, to simulate bulk and single cell transcriptional data from a known ground truth obtained from mathematical models of cellular systems. This package contains a general R infrastructure for running cell-based models and simulating gene expression data based on the model states. We show how to use this package to simulate a gene expression data set and consequently benchmark analysis methods on this data set with a known ground truth. The package is freely available via Bioconductor: http://bioconductor.org/packages/CancerInSilico/. Thomas Sherman, Luciane T. Kagohara, Raymon Cao, Matthew Satriano, Michael Considine, Gabriel Krigsfeld, Ruchira Ranaweera, Sandra A. Jablonski, Genevieve L. Stein-O'Brien, Daria A. Gaykalova, Louis M. Weiner, Christine H. Chung, Elana J. Fertig |
PLoS Comput. Biol. | 12 |
| 2018 | Splice Expression Variation Analysis (SEVA) for inter-tumor heterogeneity of gene isoform usage in cancerabstractMotivation: Current bioinformatics methods to detect changes in gene isoform usage in distinct phenotypes compare the relative expected isoform usage in phenotypes. These statistics model differences in isoform usage in normal tissues, which have stable regulation of gene splicing. Pathological conditions, such as cancer, can have broken regulation of splicing that increases the heterogeneity of the expression of splice variants. Inferring events with such differential heterogeneity in gene isoform usage requires new statistical approaches. Results: We introduce Splice Expression Variability Analysis (SEVA) to model increased heterogeneity of splice variant usage between conditions (e.g. tumor and normal samples). SEVA uses a rank-based multivariate statistic that compares the variability of junction expression profiles within one condition to the variability within another. Simulated data show that SEVA is unique in modeling heterogeneity of gene isoform usage, and benchmark SEVA's performance against EBSeq, DiffSplice and rMATS that model differential isoform usage instead of heterogeneity. We confirm the accuracy of SEVA in identifying known splice variants in head and neck cancer and perform cross-study validation of novel splice variants. A novel comparison of splice variant heterogeneity between subtypes of head and neck cancer demonstrated unanticipated similarity between the heterogeneity of gene isoform usage in HPV-positive and HPV-negative subtypes and anticipated increased heterogeneity among HPV-negative samples with mutations in genes that regulate the splice variant machinery. These results show that SEVA accurately models differential heterogeneity of gene isoform usage from RNA-seq data. Availability and implementation: SEVA is implemented in the R/Bioconductor package GSReg. Contact: [email protected] or [email protected] or [email protected]. Supplementary information: Supplementary data are available at Bioinformatics online. Bahman Afsari, Theresa Guo, Michael Considine, Liliana Florea, Luciane T. Kagohara, Genevieve L. Stein-O'Brien, Dylan Kelley, Emily Flam, Kristina D. Zambo, Patrick K. Ha, Donald Geman, Michael F. Ochs, Joseph A. Califano, Daria A. Gaykalova, Alexander V. Favorov, Elana J. Fertig |
Bioinform. | 14 |
| 2017 | PatternMarkers & GWCoGAPS for novel data-driven biomarkers via whole transcriptome NMFabstractSUMMARY: Non-negative Matrix Factorization (NMF) algorithms associate gene expression with biological processes (e.g. time-course dynamics or disease subtypes). Compared with univariate associations, the relative weights of NMF solutions can obscure biomarkers. Therefore, we developed a novel patternMarkers statistic to extract genes for biological validation and enhanced visualization of NMF results. Finding novel and unbiased gene markers with patternMarkers requires whole-genome data. Therefore, we also developed Genome-Wide CoGAPS Analysis in Parallel Sets (GWCoGAPS), the first robust whole genome Bayesian NMF using the sparse, MCMC algorithm, CoGAPS. Additionally, a manual version of the GWCoGAPS algorithm contains analytic and visualization tools including patternMatcher, a Shiny web application. The decomposition in the manual pipeline can be replaced with any NMF algorithm, for further generalization of the software. Using these tools, we find granular brain-region and cell-type specific signatures with corresponding biomarkers in GTEx data, illustrating GWCoGAPS and patternMarkers ascertainment of data-driven biomarkers from whole-genome data. AVAILABILITY AND IMPLEMENTATION: PatternMarkers & GWCoGAPS are in the CoGAPS Bioconductor package (3.5) under the GPL license. CONTACT: [email protected] or [email protected] or [email protected]. SUPPLEMENTARY INFORMATION: Supplementary data are available at Bioinformatics online. Genevieve L. Stein-O'Brien, Jacob L. Carey, Waishing Lee, Michael Considine, Alexander V. Favorov, Emily Flam, Theresa Guo, Luigi Marchionni, Thomas Sherman, Shawn Sivy, Daria A. Gaykalova, Ronald McKay, Michael F. Ochs, Carlo Colantuoni, Elana J. Fertig |
Bioinform. | 12 |